New research highlights how ivermectin disrupts early neural development, leading to significant structural and functional changes in frog embryos.

Scientists have discovered that ivermectin, a widely used antiparasitic drug, can cause severe disruptions during early neural development in frog embryos. The study, using Xenopus laevis as a model, showed that exposure to ivermectin during neurulation—the critical phase in forming the central nervous system—resulted in defects to the neural tube, which could ultimately impair brain and spinal cord development.

The research identified purinergic P2X4 signaling as a key mechanism behind these developmental issues. Ivermectin was found to alter calcium dynamics in the neurons, which are vital for normal cellular communication and development. The treated embryos exhibited pigmentation anomalies, motor paralysis, and structural abnormalities at neuromuscular junctions, including a reduction in axonal branching. These findings were specific to P2X4 receptor modulation, as other compounds targeting glycine, GABA, and nicotinic receptors did not produce similar effects.

The study underscores the importance of purinergic signaling pathways during early development, particularly the P2X4 receptor’s role in neurulation. Researchers warn that unintended consequences of ivermectin exposure during developmental stages could lead to lasting neural and physical impairments. The results highlight the need for caution in the use of drugs that can interfere with critical signaling processes, especially during sensitive periods of embryonic growth.